Blanchette V - Search Results

1

Goldman RD, Blanchette V, Koren G. Goldman RD, et al. Among authors: blanchette v. Can Fam Physician. 2003 Dec;49:1601-3. Can Fam Physician. 2003. PMID: 14708924 Free PMC article.

2

Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.

Finkelstein Y, Schechter T, Garcia-Bournissen F, Kirby M, Nurmohamed L, Juurlink DN, Blanchette V, Koren G. Finkelstein Y, et al. Among authors: blanchette v. Clin Ther. 2007 Dec;29(12):2738-43. doi: 10.1016/j.clinthera.2007.12.016. Clin Ther. 2007. PMID: 18201591

3

Anticoagulation with sodium warfarin in children: effect of a loading regimen.

Doyle JJ, Koren G, Cheng MY, Blanchette VS. Doyle JJ, et al. Among authors: blanchette vs. J Pediatr. 1988 Dec;113(6):1095-7. doi: 10.1016/s0022-3476(88)80589-4. J Pediatr. 1988. PMID: 3193316

4

Hepatotoxicity of 6-mercaptopurine in childhood acute lymphocytic leukemia: pharmacokinetic characteristics.

Berkovitch M, Matsui D, Zipursky A, Blanchette VS, Verjee Z, Giesbrecht E, Saunders EF, Evans WE, Koren G. Berkovitch M, et al. Among authors: blanchette vs. Med Pediatr Oncol. 1996 Feb;26(2):85-9. doi: 10.1002/(SICI)1096-911X(199602)26:2<85::AID-MPO3>3.0.CO;2-Q. Med Pediatr Oncol. 1996. PMID: 8531858

5

Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A.

Sharathkumar A, Lillicrap D, Blanchette VS, Kern M, Leggo J, Stain AM, Brooker L, Carcao MD. Sharathkumar A, et al. Among authors: blanchette vs. J Thromb Haemost. 2003 Jun;1(6):1228-36. doi: 10.1046/j.1538-7836.2003.00230.x. J Thromb Haemost. 2003. PMID: 12871324 Free article. Review.

6

Clinical and cost implications of target joints in Canadian boys with severe hemophilia A.

Kern M, Blanchette V, Stain AM, Einarson TR, Feldman BM. Kern M, et al. Among authors: blanchette v. J Pediatr. 2004 Nov;145(5):628-34. doi: 10.1016/j.jpeds.2004.06.082. J Pediatr. 2004. PMID: 15520762

7

Recombinant factor VIII in hemophilia A: the Canadian experience.

Blanchette VS. Blanchette VS. Blood Coagul Fibrinolysis. 1997 Aug;8 Suppl 1:S33-9. Blood Coagul Fibrinolysis. 1997. PMID: 9351535 Review.

8

Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study.

Feldman BM, Pai M, Rivard GE, Israels S, Poon MC, Demers C, Robinson S, Luke KH, Wu JK, Gill K, Lillicrap D, Babyn P, McLimont M, Blanchette VS; Association of Hemophilia Clinic Directors of Canada Prophylaxis Study Group. Feldman BM, et al. Among authors: blanchette vs. J Thromb Haemost. 2006 Jun;4(6):1228-36. doi: 10.1111/j.1538-7836.2006.01953.x. J Thromb Haemost. 2006. PMID: 16706965 Free article. Clinical Trial.

9

Central venous access devices in children with hemophilia: an update.

Blanchette VS, Al-Musa A, Stain AM, Ingram J, Fille RM. Blanchette VS, et al. Blood Coagul Fibrinolysis. 1997 Aug;8 Suppl 1:S11-4. Blood Coagul Fibrinolysis. 1997. PMID: 9351530 Review.

10

A prospective, longitudinal study of central venous catheter-related deep venous thrombosis in boys with hemophilia.

Price VE, Carcao M, Connolly B, Chait P, Daneman A, Temple M, Stain AM, Sung L, Al-Tralbosi H, Blanchette VS. Price VE, et al. Among authors: blanchette vs. J Thromb Haemost. 2004 May;2(5):737-42. doi: 10.1111/j.1538-7836.2004.00653.x. J Thromb Haemost. 2004. PMID: 15099279 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

402 results

Search Page